Seer Inc. is a life sciences company. It engages in developing Proteograph(TM), which is an integrated solution consisting of consumables, automation instrumentation and proprietary software. Seer Inc. is based in REDWOOD CITY, Calif.
| Revenue (Most Recent Fiscal Year) | $14.17M |
| Net Income (Most Recent Fiscal Year) | $-86.60M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 6.44 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.39 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -482.85% |
| Net Margin (Trailing 12 Months) | -484.51% |
| Return on Equity (Trailing 12 Months) | -25.88% |
| Return on Assets (Trailing 12 Months) | -23.07% |
| Current Ratio (Most Recent Fiscal Quarter) | 14.25 |
| Quick Ratio (Most Recent Fiscal Quarter) | 13.71 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 1.07 |
| Book Value per Share (Most Recent Fiscal Quarter) | $5.54 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.32 |
| Earnings per Share (Most Recent Fiscal Year) | $-1.35 |
| Diluted Earnings per Share (Trailing 12 Months) | $-1.36 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Common Shares Outstanding | 55.79M |
| Free Float | 49.49M |
| Market Capitalization | $105.44M |
| Average Volume (Last 20 Days) | 0.15M |
| Beta (Past 60 Months) | 1.60 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 11.28% |
| Percentage Held By Institutions (Latest 13F Reports) | 75.20% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |